Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 1/20 | 0.54 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.54 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | DPP4 | P27487 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL396883 | 0.88 | BCHE (0.49) | BCHEPTGS2PTGS1ALDH1A1ALOX15 | |
| SCHEMBL396148 | 0.86 | BCHE (0.60) | BCHEPTGS2PTGS1ALDH1A1ALOX15 | |
| SCHEMBL395394 | 0.85 | BCHE (0.62) | BCHEPTGS2PTGS1ALDH1A1ALOX15 | |
| Ampyrone SCHEMBL4648040 | 0.78 | BCHE (0.60) | BCHEPTGS2PTGS1ALDH1A1ALOX15 | |
| Ampyrone SCHEMBL8822010 | 0.77 | BCHE (0.68) | BCHEPTGS2PTGS1ALDH1A1ALOX15 | |
| SCHEMBL5039203 | 0.77 | BCHE (0.64) | BCHEPTGS2ALDH1A1ALOX15KMT2A | |
| Ampyrone SCHEMBL28606780 | 0.77 | BCHE (0.84) | BCHEPTGS2PTGS1ALDH1A1ALOX15 | |
| Ampyrone SCHEMBL133625 | 0.75 | BCHE (0.56) | BCHEPTGS2PTGS1ALDH1A1ALOX15 | |
| Ampyrone SCHEMBL27868612 | 0.75 | BCHE (0.79) | BCHEPTGS2PTGS1ALDH1A1ALOX15 | |
| SCHEMBL5823375 | 0.71 | BCHE (0.69) | BCHEPTGS2ALDH1A1ALOX15TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8101374-B2 | Oxidative chromogenic compound or salt thereof and production method thereof, and reagent composition and test instrument using the same | TERUMO KABUSHIKI KAISHA (JP) | 2012-01-24 | — | — | US | disclosed |
| EP-2138483-B1 | OXIDATIVE COLOR-DEVELOPING COMPOUNDS, SALTS THEREOF, PROCESS FOR PRODUCTION OF THE SAME, REAGENT COMPOSITIONS AND TEST TOOLS MADE BY USING THE SAME | TERUMO CORP (JP) | 2011-05-18 | — | — | EP | disclosed |
| US-20100062464-A1 | OXIDATIVE CHROMOGENIC COMPOUND OR SALT THEREOF AND PRODUCTION METHOD THEREOF, AND REAGENT COMPOSITION AND TEST INSTRUMENT USING THE SAME | TERUMO KABUSHIKI KAISHA (JP) | 2010-03-11 | — | — | US | disclosed |
| EP-2138483-A1 | OXIDATIVE COLOR-DEVELOPING COMPOUNDS, SALTS THEREOF, PROCESS FOR PRODUCTION OF THE SAME, REAGENT COMPOSITIONS AND TEST TOOLS MADE BY USING THE SAME | Terumo Kabushiki Kaisha (JP) | 2009-12-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100062464-A1 | OXIDATIVE CHROMOGENIC COMPOUND OR SALT THEREOF AND PRODUCTION METHOD THEREOF, AND REAGENT COMPOSITION AND TEST INSTRUMENT USING THE SAME | SCO2, CBR3, CYP11B1 | BCHE 1213/4885PTGS2 2327/4885PTGS1 1444/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.